CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 
 
 


<
Johnson & Johnson  (JNJ)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 



 

Johnson & Johnson

JNJ's Financial Statements and Analysis






Johnson & Johnson reported in II. Quarter net earnings per share of $1.45 an increase by 3.57 % year on year from $1.40 and decline of -9.38 % from $1.60 earned in I. Quarter (Apr 01 2018).

Johnson & Johnson's Revenue rose by % in II. Quarter (Jul 01 2018) year on year, to $20,830 million and advanced by 4.1 % sequentially.


Johnson & Johnson is Expected to report next financial results on October 15, 2018.
More on JNJ's Income Statement

II. Quarter
Earnings Per Share Revenues
$ 1.45 $  20,830 Mill
$+0.05     +3.57 % $+1,991M     +10.57 %
You need to upgrade your Flash Player


       
  • PROCRIT 77.52% Y/Y,
• RISPERDAL 76.41% Y/Y,
• REMICADE 83.39% Y/Y,
• VELCADE 75.58% Y/Y,
• CONCERTA 218.52% Y/Y,
• INVEGA 105.77% Y/Y
   
     
       
  • Other -2.12% Y/Y,
• Total Pharmaceutical -4.35% Y/Y,
• Med. Dev. & Diag. -3.24% Y/Y,
• Nutritionals -4.42% Y/Y,
• Skin Care -2.83% Y/Y,
• Total Consumer -2.95% Y/Y
   
     


JNJ's Segments

JNJ's NET INCOME

Johnson & Johnson's net income of $3,954 million in II. Quarter increased by 3.32 % from net earnings of $3,827 million achieved in II. Quarter a year ago.

Sequentially net earnings fell by -9.46 % from net income of $4,367.00 million realized in previous quarter.

More on JNJ's Growth



Johnson & Johnson Income Growth by Division
• Total Pharmaceutical 39.91% Y/Y,
• Total Consumer 232.92% Y/Y • Med. Dev. & Diag. -11.36% Y/Y Inventories Inventories declined by -9.17 % to $8,810.00 million from II. Quarter a year ago, sequentially inventories fell by -2.26 %. JNJ's Cash flow In II. Quarter company's net cash flow was $2,930 million, capital expenditures fell by 27.00%, to $-875 millions compare to same quarter a year ago and fell by 32.98% from I. Quarter (Apr 01 2018).

More on JNJ's Cash flow Statement



Johnson & Johnson payed out dividend of $3.42 per share in last 52 weeks representing 657.69 % of net earning per share in trailing twelve-month period.

During the same period Johnson & Johnson earned $ 8.10 cash per share, on a free-cash flow basis 1558.64 % of net earning per share.

Book value fell by -0.19 % sequentially to $23.11 per share.
Tangible Book value grew to $ -6.44 per share from $ -7.42.

Company repurchased 10.60 million shares or 0.39 % in II. Quarter.
Interest Coverage Ratio was 18.54. Debt Coverage Ratio was 0.56.

More on JNJ's Dividends
 Market Capitalization (Millions) 377,281
 Shares Outstanding (Millions) 2,721
 Total Debt (Millions $) 32,083
 Revenue (TTM) (Millions $) 80,684
 Net Income (TTM) (Millions $) 1,372
 Cash Flow (TTM) (Millions $) 4,971
 Capital Exp. (TTM) (Millions $) -3,563
 Dividend TTM ($) 3.42 $
 Dividend Yield TTM (%) 2.6 %
 Employees (TTM) $ 126,500





Johnson & Johnson payed out dividend of $3.42 per share in last 52 weeks representing 657.69 % of net earning per share in trailing twelve-month period.

During the same period Johnson & Johnson earned $ 8.10 cash per share, on a free-cash flow basis 1558.64 % of net earning per share.

Book value fell by -0.19 % sequentially to $23.11 per share.
Tangible Book value grew to $ -6.44 per share from $ -7.42.

Company repurchased 10.60 million shares or 0.39 % in II. Quarter.
Interest Coverage Ratio was 18.54. Debt Coverage Ratio was 0.56.

More on JNJ's Dividends
 Market Capitalization (Millions) 377,281
 Shares Outstanding (Millions) 2,721
 Total Debt (Millions $) 32,083
 Revenue (TTM) (Millions $) 80,684
 Net Income (TTM) (Millions $) 1,372
 Cash Flow (TTM) (Millions $) 4,971
 Capital Exp. (TTM) (Millions $) -3,563
 Dividend TTM ($) 3.42 $
 Dividend Yield TTM (%) 2.6 %
 Employees (TTM) $ 126,500


   

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

RZZN's Profile

Stock Price

RZZN's Financials

Business Description

Fundamentals

Charts & Quotes

RZZN's News

Suppliers

RZZN's Competitors

Customers & Markets

Economic Indicators

RZZN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071